학술논문
Dapagliflozin and new-onset type 2 diabetes in patients with chronic kidney disease or heart failure: pooled analysis of the DAPA-CKD and DAPA-HF trials
Document Type
Article
Author
Rossing, Peter; Inzucchi, Silvio E; Vart, Priya; Jongs, Niels; Docherty, Kieran F; Jhund, Pardeep S; Køber, Lars; Kosiborod, Mikhail N; Martinez, Felipe A; Ponikowski, Piotr; Sabatine, Marc S; Solomon, Scott D; DeMets, David L; Bengtsson, Olof; Lindberg, Magnus; Langkilde, Anna Maria; Sjöstrand, Mikaela; Stefansson, Bergur V; Karlsson, Cecilia; Chertow, Glenn M; Hou, Fan Fan; Correa-Rotter, Ricardo; Toto, Robert D; Wheeler, David C; McMurray, John J V; Heerspink, Hiddo J L
Source
In The Lancet Diabetes & Endocrinology January 2022 10(1):24-34
Subject
Language
ISSN
2213-8587